General
Preferred name
KETOBEMIDONE
Synonyms
IDS-NK-001(SECT.3) ()
Cetobemidone ()
Ketogan ()
NSC-117863 ()
Ketodur ()
A 21 lundbeck ()
Ciba 7115 ()
Cliradone ()
Cetobemidona ()
Ketorax ()
IDS-NK-001 ()
Cymidon ()
P&D ID
PD009240
CAS
469-79-4
Tags
available
drug
First approval
1947
Drug indication
Pain
Drug Status
approved
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
MOA
Ketobemidone (Cliradon, Ketogan, Ketodur, Cymidon, Ketorax, &c.) is a powerful opioid analgesic. It also has some NMDA-antagonist properties. This makes it useful for some types of pain that don't respond well to other opioids. The most commonly cited equalisation ratio for analgesic doses is 25 mg of ketobemidone hydrobromide to 60 mg of morphine hydrochloride or sulfate and circa 8 mg of ketobemidone by injection.
HALF-LIFE
Plasma half-life: 2.42 +/- 0.41 h (m +/- SD).; Elimination half-life: 3.27 +/- 0.32 h
TOXICITY
Base: Rat Intravenous LD50: 10 mg/kg; Mouse Intravenous LD50: 14 mg/kg.; Hydrochloride salt: Rat Oral LD50: 215 mg/kg; Rat Intravenous LD50: 40 mg/kg;
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
22
Molecular Weight
247.16
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
2.33
TPSA
40.54
Fraction CSP3
0.53
Chiral centers
0.0
Largest ring
6.0
QED
0.89
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data

